From the Archives: Naheed Kurji of Recursion Takes a Deep Dive into Artificial Intelligence for Drug Discovery
For this StartUp Health NOW episode, we dive back into an interview we did with a long-time Health Transformer, Naheed Kurji. At the time of the interview, Naheed was the CEO, President & Co-founder of Cyclica, a StartUp Health company that is considered one of the pioneers of what is now the increasingly hot space of using AI for drug discovery and development.
We wanted to revisit this conversation because in the time since we aired it, Cyclica had huge news. In May 2023, the company was acquired by Recursion Pharmaceuticals (NASDAQ: RXRX), a clinical-stage biotech player.
Naheed now leads Recursion’s Canadian operations and is putting his experience to use accelerating innovation in drug discovery in whole new ways. By looking back at Naheed’s experience at Cyclica, we can gain a glimpse into how he was so successful piloting a startup from launch to acquisition and how he might lead Recursion moving forward. Naheed will also give us an inside look at how Cyclica reshaped this market – then he’ll zoom way out: as the chair of the Alliance for Artificial Intelligence in Health, Naheed can help us understand where the AI for health industry is going.
We will be back with fresh episodes after Labor Day!
Funders: Become a Health Moonshot Champion
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.
Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.
